In: European Journal of Epidemiology, 2015, vol. 30, no. 12, p. 1287-1298
|
In: European Journal of Epidemiology, 2015, vol. 30, no. 12, p. 1333-1334
|
In: European Journal of Nutrition, 2015, vol. 54, no. 1, p. 139-148
|
In: Quality of Life Research, 2015, vol. 24, no. 9, p. 2151-2161
|
In: European Journal of Epidemiology, 2015, vol. 30, no. 12, p. 1263-1275
|
In: Journal of General Internal Medicine, 2015, vol. 30, no. 1, p. 17-24
|
In: Blood, 2020, vol. 137, no. 10, p. 1365–1376
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B cell receptor immunoglobulins (BcR IG). Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR IG stereotypy in CLL has important implications for understanding disease...
|
In: Haematologica, 2020, vol. 105, no. 2, p. 448-456
BIRC3 is a recurrently mutated gene in chronic lymphocytic leukemia (CLL) but the functional implications of BIRC3 mutations are largely unexplored. Furthermore, little is known about the prognostic impact of BIRC3 mutations in CLL cohorts homogeneously treated with first-line fludarabine, cyclophosphamide, and rituximab (FCR). By immunoblotting analysis, we showed that the non-canonical...
|
In: Supportive Care in Cancer, 2014, vol. 22, no. 2, p. 339-349
|
In: European Journal of Pediatrics, 2014, vol. 173, no. 4, p. 457-462
|